Socioeconomic costs of amyotrophic lateral sclerosis according to staging system

References

• Bae J, Hong Y, Baek W, Sohn E, Cho J, Kim B, et al. Current Status of the Diagnosis and Management of Amyotrophic Lateral Sclerosis in Korea: A Multi-Center Cross-Sectional Study. J Clin Neurol. 2012;8:293–300.
   PubMed Web of Science ®Google Scholar
• Mehal JM, Holman RC, Schonberger LB, Sejvar JJ. Amyotrophic lateral sclerosis/motor neuron disease deaths in the United States, 1999–2009. Amyotroph Lateral Scler Frontotemporal Degener. 2013;14:346–52.
   PubMed Web of Science ®Google Scholar
• Miller RG, Jackson CE, Kasarskis EJ, England JD, Forshew D, Johnston W, et al. Practice parameter update: the care of the patient with amyotrophic lateral sclerosis. Drug, nutritional, and respiratory therapies (an evidence based review): report of the Quality Standards Subcommittee of the American Academy of Neurology. Neurology. 2009;73:1218–26.
   PubMed Web of Science ®Google Scholar
• Larkindale J, Yang W, Hogan PF, Simon CJ, Zhang Y, Jain A, et al. Cost of illness for neuromuscular diseases in the United States. Muscle Nerve. 2014;49:431–8.
   PubMed Web of Science ®Google Scholar
• Schepelmann K, Winter Y, Spottke AE, Claus D, Grothe C, Schröder R, et al. Socioeconomic burden of amyotrophic lateral sclerosis, myasthenia gravis and facioscapulohumeral muscular dystrophy. J Neurol. 2010;257:15–23.
   PubMed Web of Science ®Google Scholar
• López-Bastida J, Perestelo-Perez L, Monton-Alvarez F, Serrano-Aguilar P, Alfonso-Sanchez JL. Social economic costs and health-related quality of life in patients with amyotrophic lateral sclerosis in Spain. Amyotroph Lateral Scler. 2009;10:237–43.
   PubMed Web of Science ®Google Scholar
• van der Steen I, van den Berg J-P, Buskens E, Lindeman E, van den Berg LH. The costs of amyotrophic lateral sclerosis, according to type of care. Amyotroph Lateral Scler. 2009; 10:27–34.
   PubMed Web of Science ®Google Scholar
• Policies (Internet). Sejong: Korea Ministry of Health and Welfare; (date unknown; cited 2013 Dec 31). Available from: http://english.mw.go.kr/.
   Google Scholar
• OECD. Health at a Glance 2013: OECD Indicators (Internet). OECD Publishing; 2013. Available from: http://dx.doi.org/10.1787/health_glance-2013-en.
   Google Scholar
• Roche JC, Ricardo Rojas-Garcia, Scott KM, Scotton W, Ellis CE, Burman R, et al. A proposed staging system for amyotrophic lateral sclerosis. Brain. 2012;135: 847–52.
   PubMed Web of Science ®Google Scholar
• Brooks BR, Miller RG, Swash M, Munsat TL. El Escorial revisited: revised criteria for the diagnosis of amyotrophic lateral sclerosis. Amyotroph Lateral Scler Other Motor Neuron Disord. 2000;1:293–9.
   PubMed Web of Science ®Google Scholar
• Kim H, Park K, Koh S, Lee S. Korean version of amyotrophic lateral sclerosis functional rating scale-revised: A pilot study on the reliability and validity. J Korean Neurol Assoc. 2007;25:149–54.
   Google Scholar
• Rice D. Estimating the cost of illness. Am J Public Health. 1967;57:424–40.
   PubMed Web of Science ®Google Scholar
• Mok SA, Cho MO. Utilization of alternative complementary remedies of stroke patients. J Korean Acad Adult Nurs. 2004;16:432–41.
   Google Scholar
• Wage and working hours (Internet). Sejong: Ministry of Employment and Labor; (date unknown; cited 2013 Dec 2). Available from: http://www.moel.go.kr/.
   Google Scholar
• Average Foreign Exchange Rate (Internet). Seoul: Korea Exchange Bank; (date unknown; cited 2014 Jan 5). Available from: http://www.keb.co.kr/.
   Google Scholar
• Xu K, Evans DB, Kawabata K, Zeramdini R, Klavus J, Murray CJL. Household catastrophic health expenditure: a multicountry analysis. Lancet. 2003;362:111–7.
   PubMed Web of Science ®Google Scholar
• Wasner M, Klier H, Borasio GD. The use of alternative medicine by patients with amyotrophic lateral sclerosis. J Neurol Sci. 2001;191:151–4.
   PubMed Web of Science ®Google Scholar
• Yun MH, Choi-Kwon S. Quality of life and the factors related to family caregivers caring for those with amyotrophic lateral sclerosis. Perspect Nurs Sci. 2011;8: 62–72.
   Google Scholar
• Chio A, Gauthier A, Vignola A, Calvo A. Caregiver time use in ALS. Neurology. 2006;67:902–4.
   PubMed Web of Science ®Google Scholar
• Kim M, Shin H, Min Y. Correlation between Severe ALS Patient-Caregiver Couples’ Characteristics and Caregivers’ Health Related Quality of Life. J Korean Acad Nurs. 2011;41:354–63.
   PubMed Web of Science ®Google Scholar
• Kim HY, Kim H, Oh KW, Oh SI, Koh SH, Baik W. Biological markers of mesenchymal stromal cells as predictors of response to autologous stem cell transplantation in patients with amyotrophic lateral sclerosis: an investigator-initiated trial and in vivo study. Stem Cells. 2014;32: 2724–31.
   PubMed Web of Science ®Google Scholar
• Kim HY, Moon C, Kim KS, Oh KW, Oh S-i, Kim J. Recombinant human erythropoietin in amyotrophic lateral sclerosis: a pilot study of safety and feasibility. J Clin Neurol. 2014;10:342–7.
   PubMed Web of Science ®Google Scholar